ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Synthetic Biology Market 2017 | Industry Forecast Research Report Till 2024 – Real Facts

Synthetic Biology Market 2017 | Industry Forecast Research Report Till 2024Real FactsSynthetic Biology Market report is a definitive source of information which provides latest market research intelligence, industry trend, emerging markets, products, t… Continue reading

2018-04-03 Michael Zand NEWS

A CRISPR picture – patent filing and litigation trends – Managing Intellectual Property

A CRISPR picture – patent filing and litigation trendsManaging Intellectual PropertyPatent filing trends for the gene editing technology indicate a near 200% increase globally between 2013 and 2015, and a continuing boom since. Patrick Wingrove investi… Continue reading

2018-04-03 Michael Zand NEWS

Stanford scientists combine CRISPR and DNA barcoding to track cancer growth – Stanford University News

Stanford University NewsStanford scientists combine CRISPR and DNA barcoding to track cancer growthStanford University NewsThe team achieved this result using CRISPR-Cas9 – a powerful gene-editing tool that can easily replace, modify, or delete genetic… Continue reading

2018-04-03 Michael Zand NEWS

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen … – Dove Medical Press

Metformin inhibits proliferation and cytotoxicity and induces apoptosis via AMPK pathway in CD19-chimeric antigen …Dove Medical PressBackground: CD19-chimericantigen receptor (CAR) modified T cells (CD19-CAR T cells) have been well documented to poss… Continue reading

2018-04-03 Michael Zand NEWS

Analyzing ArQule (ARQL) and Editas Medicine (EDIT) – registrarjournal.com

Analyzing ArQule (ARQL) and Editas Medicine (EDIT)registrarjournal.comIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) compl… Continue reading

2018-04-03 Michael Zand NEWS

Critical Survey: OpGen (OPGN) versus Editas Medicine (EDIT) – The Ledger Gazette

Critical Survey: OpGen (OPGN) versus Editas Medicine (EDIT)The Ledger GazetteIt is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (… Continue reading

2018-04-03 Michael Zand NEWS

Gene therapy is now available, but could cost millions over a lifetime, says scientists – The Independent

Continue reading

2018-04-03 Michael Zand NEWS

A Journal Retracted A Controversial Paper About CRISPR. The Damage Might Already Be Done. – Futurism


The Independent

Gene therapy is now available, but could cost millions over a lifetime, says scientists
The Independent
If you were born with a rare form of blindness, there is now a treatment for you that may restore your eyesight. That’s because gene therapies became a clinical reality in 2017. Yet many people with rare diseases that could be treated in this way may …

Continue reading

2018-04-02 Michael Zand NEWS
  • 1
  • …
  • 311
  • 312
  • 313
  • 314
  • 315
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

WIRED

A Journal Retracted A Controversial Paper About CRISPR. The Damage Might Already Be Done.
Futurism
A scientific journal just retracted a controversial study that claimed the gene editing tool CRISPR causes a number of unintended mutations, but it may be too late to undo the damage the paper caused. Let’s walk it back a second. In May 2017, well …
A Flawed Study Shows How Little We Understand Crispr’s Effects …WIRED
Scientific journal officially retracts controversial CRISPR studyNew Atlas
Paper on Off-Target CRISPR Effects PulledGenomeWeb
Business Insider –Daily Mail –IFLScience –bioRxiv
all 18 news articles »